CClinicalTrials.gg
Status unknownNCT01702870Updated Oct 18, 2012

Diagnostic Accuracy of MR in Myositis

An observational study in Myositis and Muscular Disorders, Atrophic, sponsored by University of Warwick. Status unknown at 3 sites in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-18.

Sponsored by University of Warwick · Observational

The sponsor has not verified this record recently (last verified Oct 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

A prospective observational study to determine the effectiveness of magnetic resonance (MR) imaging in the diagnosis and monitoring of idiopathic myopathy in adult humans.

Read the detailed description

Idiopathic inflammatory myopathies are a heterogeneous group of conditions characterised by skeletal muscle inflammation leading to proximal muscle weakness, often with tenderness, and occasionally dermatological manifestations. Diagnosis is clinical and is based on the Bohan and Peter criteria which comprises clinical examination, serological markers, electromyography (EMG) and muscle biopsy. This has relatively poor sensitivity and specificity. Muscle biopsy in particular has a false negative rate of 10-15% and is invasive. Clinical criteria also lack the discriminatory power to differentiate between recurrent (or breakthrough) myopathy and myopathy secondary to treatment with corticosteroid.

Magnetic resonance (MR) imaging has the advantage of being non-invasive, and is able to discriminate between different tissues, and to identify areas of inflammation. The aim of this study is to assess the effectiveness of MR sequences in the diagnosis of myopathy, monitoring of treatment response, and in differentiating between breakthrough myopathy and steroid-induced myopathy.

02

Conditions studied

  • Myositis
  • Muscular Disorders, Atrophic

Keywords

  • Magnetic resonance imaging
03

In context

Myositis

242 studies on the registry are indexed under Myositis; 103 are open to participants now.

This study's planned enrollment of 70 is below the median of 226 across 72 observational studies indexed under Myositis.

Browse Myositis studies →

Lead sponsor

University of Warwick is the lead sponsor of 26 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study group will be patients attendeing rheumatology outpoatient clinics with a suspected diagnosis of myopathy based on clinical criteria

Inclusion criteria

  • Any adult patient referred for an MR scan with a suspected clinical diagnosis of myopathy.

Exclusion criteria

Exclusion Criteria:

  • Patient unable or unwilling to have an MR scan.
  • Standard MR exclusion criteria will apply.
05

Study design

Time perspective
Prospective
Enrollment
70 participants (estimated)

Groups and cohorts

  • Suspected myositis

    Participants with suspected myositis based on clinical criteria (Bohan and Peters criteria) referred for Magnetic resonance imaging

    Procedure: Magnetic Resonance Imaging

  • Controls

    Normal volunteers without myositis, who will undergo MR imaging to establish normal ranges of MR signal in health muscle

    Procedure: Magnetic Resonance Imaging

Interventions

  • ProcedureMagnetic Resonance Imaging

    Also known as: Magnetic Resonance Imaging of the thighs

06

What researchers measure

Primary outcomes

  1. MR signal (T1w, T2w and STIR sequences) in muscle.

    The correlation between MR signal and the clinical criteria will be measured

    Time frame: 2 years

Secondary outcomes

  1. Correlation between MR appearances (T1w, T2w and STIR signal on MR)and the symptom severity (Bohan and Peter criteria)

    Time frame: 2 years

  2. Difference in MR signal between myopathy and steroid-induced myopathy, with sensitivity and specificity

    Time frame: 2 years

Other outcomes

  1. Sensitivity and specificity of MR against the gold standard of clinical criteria

    The MR signal will be compared against the Bohan and Peters criteria (the current gold standard) to determine sensitivity and specificity of the technique

    Time frame: 2 years

07

Study locations

3 sites
  • Salford Royal NHS Foundation Trust
    Salford, Lancashire M6 8HD, United Kingdom
  • George Eliot Hospital NHS Trust
    Nuneaton, Warwickshire CV10 7DJ, United Kingdom
  • University Hospitals Coventry and Warwickshire NHS Trust
    Coventry, West Midlands CV2 2DX, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01702870
Lead sponsor
University of Warwick
Collaborators
West Midlands Comprehensive Local Research Network, University Hospitals Coventry and Warwickshire NHS Trust, Northern Care Alliance NHS Foundation Trust, The Royal College of Radiologists
Responsible party
Dr. Terence Jones (Clinical Research Fellow in Radiology, University of Warwick) — Principal investigator
First posted
Oct 10, 2012
Start date
Nov 2012
Completion
Nov 2014 (estimated)
Last update
Oct 18, 2012

Study contacts

Terence Jones, MBChB FRCR
Contact
t.a.jones@warwick.ac.uk
Charles Hutchinson, MD FRCR
study chair · Professor of Imaging (Radiology), University of Warwick
Terence Jones, MBChB FRCR
principal investigator · Clinical Research fellow in Radiology, University of Warwick

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion